SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-495444
Filing Date
2016-03-07
Accepted
2016-03-07 17:28:37
Documents
2
Period of Report
2016-03-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d148689d8k.htm 8-K 17265
2 EX-10.1 d148689dex101.htm EX-10.1 142316
  Complete submission text file 0001193125-16-495444.txt   160664
Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Filer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36297 | Film No.: 161489596
SIC: 2834 Pharmaceutical Preparations